13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001584258
Total reported value
$1.1B
$1.1B
10 檔
5.6%
In Q4 2024, Dumac, Inc.'s U.S. equity holdings reached a combined market value of $1.1B, distributed across 10 disclosed stock positions.
Dumac, Inc. executed strategic sector rebalancing during Q4 2024, establishing 2 new positions while fully exiting 2 holdings and trimming 1 positions.
In terms of portfolio concentration, the top 5 core holdings (including UTI, INDA, DESPEGAR.COM CORP) accounted for 5.6% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UTI | Universal Technical Institut | Stock-Other | 66.73% | — | — | |
| 2 | INDA | Ishares Msci India ETF | ETF-Other | 8.61% | -0.24% | — | |
| 3 | ✓ | Despegar.com CORP | Stock-Other | 7.54% | — | +16.47% | |
| 4 | MMYT | MakeMyTrip Limited | Stock-Other | 6.99% | -0.05% | — | |
| 5 | KSPI | Jsc Kaspi.kz Adr | Stock-Other | 4.61% | -0.03% | +24.30% | |
| 6 | ZTO | Zto Express Cayman Inc-adr | Stock-Other | 2.92% | -0.30% | EXIT | |
| 7 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 1.14% | — | -13.66% | |
| 8 | ARCO | Arcos Dorados Holdings Inc. | Stock-Other | 0.68% | -0.02% | — | |
| 9 | IHS | IHS Holding Limited | Stock-Other | 0.50% | — | — | |
| 10 | ACHV | Achieve Life Sciences Inc | Stock-Other | 0.27% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | UTI | Universal Technical Institut | +66.7% | NEW | New buy |
| 2 | ACHV | Achieve Life Sciences Inc | +0.3% | NEW | New buy |
| 3 | SGMT | Sagimet Biosciences Inc-a | -0.6% | -13.66% | Trim |
| 4 | ✓ | Rigel Resource Acq CORP | -0.6% | EXIT | Sold out |
| 5 | IHS | IHS Holding Limited | -0.6% | — | Unchanged |
| 6 | ARCO | Arcos Dorados Holdings Inc. | -1% | — | Unchanged |
| 7 | ✓ | Despegar.com CORP | -1.2% | +16.47% | Add |
| 8 | KSPI | Jsc Kaspi.kz Adr | -4.1% | +24.30% | Add |
| 9 | ZTO | Zto Express Cayman Inc-adr | -4.9% | — | Unchanged |
| 10 | MMYT | MakeMyTrip Limited | -5.2% | — | Unchanged |
| 11 | INDA | Ishares Msci India ETF | -11.5% | — | Unchanged |
| 12 | RIGL | Rigel Pharmaceuticals, Inc. | -37.3% | EXIT | Sold out |
According to official SEC Form 13F filings, Dumac, Inc. reported a total U.S. public equity portfolio value of $1.1B across 10 disclosed positions in Q4 2024.
During Q4 2024, Dumac, Inc.'s top holdings by market value included UTI (66.7%)、INDA (8.6%)、DESPEGAR.COM CORP (7.5%). The largest single position, UTI, represented 66.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
UTI
市值: $43.2M
Top Position Liquidated / Trimmed
RIGL
前期市值: $11.5M
In Q4 2024, Dumac, Inc. made 7 total portfolio adjustments, initiating 2 new buys, adding to 2 positions, trimming 1 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.